Literature DB >> 24284968

Voltage-gated and ATP-sensitive K+ channels are associated with cell proliferation and tumorigenesis of human glioma.

Qin Ru1, Xiang Tian1, Yu-Xiang Wu1, Ri-Hui Wu1, Ming-Shan Pi1, Chao-Ying Li1.   

Abstract

Increasing evidence indicates that potassium (K+) channels play important roles in the growth and development of human cancer. In the present study, we investigated the contribution of and the mechanism by which K+ channels control the proliferation and tumor development of U87-MG human glioma cells. A variety of K+ channel blockers and openers were used to differentiate the critical subtype of K+ channels involved. The in vitro data demonstrated that selective blockers of voltage-gated K+ (K(V)) channels or ATP-sensitive K+ (K(ATP)) channels significantly inhibited the proliferation of U87-MG cells, blocked the cell cycle at the G0/G1 phase and induced apoptosis. In the U87-MG xenograft model in nude mice, K(V) or K(ATP) channel blockers markedly suppressed tumor growth in vivo. Furthermore, electrophysiological results showed that KV or KATP channel blockers inhibited K(V)/K(ATP) channel currents as well as cell proliferation and tumor growth over the same concentration range. In contrast, iberiotoxin, a selective blocker of calcium-activated K+ channels, had no apparent effect on the cell proliferation, cell cycle or apoptosis of U87-MG cells. In addition, the results of fluorescence assays indicated that blockers of K(V) or K(ATP) channels attenuated intracellular Ca2+ signaling by blocking Ca2+ influx in U87-MG cells. Taken together, these data suggest that K(V) and K(ATP) channels play important roles in the proliferation of U87-MG cells and that the influence of K(V) and K(ATP) channels may be mediated by a Ca2+-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24284968     DOI: 10.3892/or.2013.2875

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

Review 1.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 2.  Curcumin and Gastric Cancer: a Review on Mechanisms of Action.

Authors:  Tohid Hassanalilou; Saeid Ghavamzadeh; Leila Khalili
Journal:  J Gastrointest Cancer       Date:  2019-06

3.  The role of potassium channels in the proliferation and migration of endometrial adenocarcinoma HEC1-A cells.

Authors:  Emel Erdem Kış; R Nalan Tiftik; Khairat Al Hennawi; İsmail Ün
Journal:  Mol Biol Rep       Date:  2022-05-13       Impact factor: 2.742

Review 4.  Potassium channel dysfunction in neurons and astrocytes in Huntington's disease.

Authors:  Xiao Zhang; Jie-Qing Wan; Xiao-Ping Tong
Journal:  CNS Neurosci Ther       Date:  2018-01-27       Impact factor: 5.243

Review 5.  Two-Pore Domain Potassium Channel in Neurological Disorders.

Authors:  Punita Aggarwal; Sanjiv Singh; V Ravichandiran
Journal:  J Membr Biol       Date:  2021-06-24       Impact factor: 1.843

6.  Curcumin inhibits proliferation of gastric cancer cells by impairing ATP-sensitive potassium channel opening.

Authors:  Xiaohong Liu; Kai Sun; Ailin Song; Xiaoyun Zhang; Xu Zhang; Xiaodong He
Journal:  World J Surg Oncol       Date:  2014-12-19       Impact factor: 2.754

Review 7.  Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer.

Authors:  R J Klement; M K Fink
Journal:  Oncogenesis       Date:  2016-02-15       Impact factor: 7.485

8.  A single conserved basic residue in the potassium channel filter region controls KCNQ1 insensitivity toward scorpion toxins.

Authors:  Zongyun Chen; Youtian Hu; Bin Wang; Zhijian Cao; Wenxin Li; Yingliang Wu
Journal:  Biochem Biophys Rep       Date:  2015-07-21

9.  Regulation of voltage-gated potassium channels attenuates resistance of side-population cells to gefitinib in the human lung cancer cell line NCI-H460.

Authors:  Seon Young Choi; Hang-Rae Kim; Pan Dong Ryu; So Yeong Lee
Journal:  BMC Pharmacol Toxicol       Date:  2017-02-21       Impact factor: 2.483

10.  Anthelminthic activity of glibenclamide on secondary cystic echinococcosis in mice.

Authors:  Julia A Loos; María Sandra Churio; Andrea C Cumino
Journal:  PLoS Negl Trop Dis       Date:  2017-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.